verapamil has been researched along with Memory Disorders in 5 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Memory Disorders: Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sang, Z | 2 |
| Pan, W | 1 |
| Wang, K | 2 |
| Ma, Q | 1 |
| Yu, L | 1 |
| Yang, Y | 1 |
| Bai, P | 2 |
| Leng, C | 1 |
| Xu, Q | 1 |
| Li, X | 1 |
| Tan, Z | 1 |
| Liu, W | 1 |
| Zhang, P | 1 |
| Shi, J | 1 |
| Cheng, X | 1 |
| Zhang, Q | 1 |
| Zheng, C | 1 |
| Cheng, Y | 1 |
| Yang, J | 1 |
| Lu, X | 1 |
| Nikpour, M | 1 |
| Sharafi, A | 1 |
| Hamidi, M | 1 |
| Andalib, S | 1 |
| Rashidy-Pour, A | 1 |
| Vafaei, AA | 1 |
| Taherian, AA | 1 |
| Miladi-Gorji, H | 1 |
| Sadeghi, H | 1 |
| Fathollahi, Y | 1 |
| Bandegi, AR | 1 |
| Heim, C | 1 |
| Sieklucka, M | 1 |
| Sontag, KH | 1 |
5 other studies available for verapamil and Memory Disorders
| Article | Year |
|---|---|
Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Blood-Brain Barrier; Butyrylcholine | 2017 |
Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Biological Tr | 2019 |
Effect of Colloidal Aqueous Solution of Fullerene (C60) in the Presence of a P-Glycoprotein Inhibitor (Verapamil) on Spatial Memory and Hippocampal Expression of Sirtuin6, SELADIN1, and AQP1 Genes in a Rat Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Aquaporin 1; ATP Binding Cassette Transporter, Subfamily B; Disease Mode | 2020 |
Verapamil enhances acute stress or glucocorticoid-induced deficits in retrieval of long-term memory in rats.
Topics: Analysis of Variance; Animals; Avoidance Learning; Calcium Channel Blockers; Corticosterone; Electro | 2009 |
Levemopamil injection after cerebral oligemia reduces spatial memory deficits in rats.
Topics: Acetylcholine; Animals; Brain Chemistry; Calcium Channel Blockers; Carotid Arteries; gamma-Aminobuty | 1994 |